Tech Company Financing Transactions
Injective Protocol Funding Round
Injective Protocol, operating out of New York, secured $10 million from BlockTower Capital, Cadenza Capital Management and CMS Holdings.
Transaction Overview
Company Name
Announced On
4/21/2021
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
FinTech
Mailing Address
Undisclosed
New York, NY 10006
USA
New York, NY 10006
USA
Phone
Undisclosed
Website
Email Address
Overview
Access limitless markets with zero barriers. Injective is the first front-running resistant, layer-2 exchange protocol that unlocks the full potential of borderless decentralized finance (DeFi) by supporting margin trading, derivatives, and futures. Injective is backed by industry titans such as Pantera Capital, Binance, and Hashed.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Chen
Chief Technical Officer
Albert Chon
Browse more venture capital transactions:
Prev: 4/21/2021: Code Biotherapeutics venture capital transaction
Next: 4/22/2021: Replica venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs